Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Idioma
Tipo del documento
Intervalo de año de publicación
2.
Lik Sprava ; (5-6): 123-5, 2001.
Artículo en Ruso | MEDLINE | ID: mdl-11881346

RESUMEN

Results are presented of studies on local nonspecific defence in patients with protracted pneumonia in the bronchoalveolar lavage fluid (BALF) during the course of conventional therapy involving the use of T-activin and extractum Glycerrhiza glabra L. The course of conventional therapy has not been shown to be associated with a substantial normalization of cytosis in the BALF cell precipitate or augmentation of sIgA content of lysozyme. T-activin makes for a reduction in the content of mature neutrophilous granulocytes and for an increase in humoral factors of defence. Extractum Glycerrhiza glabra L. has been found to be superior to T-activin in diminishing neutrophilic granulocytes count, increase in the BALF content of macrophages, lysozyme, s IgA; it proved to be endowed with an antiphospholipase activity, which facts predetermine apperant efficacy of the drug with respect to the lung local defence system in those patients presenting with protracted pneumonia.


Asunto(s)
Extractos Vegetales/uso terapéutico , Neumonía/tratamiento farmacológico , Adyuvantes Inmunológicos/uso terapéutico , Formación de Anticuerpos/efectos de los fármacos , Líquido del Lavado Bronquioalveolar/citología , Enfermedad Crónica , Humanos , Macrófagos/citología , Macrófagos/efectos de los fármacos , Muramidasa/química , Muramidasa/efectos de los fármacos , Neutrófilos/citología , Neutrófilos/efectos de los fármacos , Péptidos/uso terapéutico , Fosfolipasas/antagonistas & inhibidores , Fosfolipasas/efectos de los fármacos , Extractos del Timo/uso terapéutico
3.
Farmakol Toksikol ; 54(3): 47-50, 1991.
Artículo en Ruso | MEDLINE | ID: mdl-1915823

RESUMEN

The results of the comparative study on the contents and activity of the enzymes of the system of oxidases of mixed function in the lungs and liver in rabbits, the specific features of phospholipid spectrum in the supernatant and microsomal fractions of the lungs and liver tissues are presented. The same parameters were investigated in experimental chronic inflammatory diseases of the lungs. The degree of the damage of the monoxygenase capacity of the lungs and the degree of the liver involvement in the process were established. The peculiarities of the inhibitory action of cimetidine on the detoxication capacity of the lungs and liver and on the disorder of the reproduction of phospholipids in these organs were revealed. The substrate specificity of cimetidine in inhibition of microsomal NADPN-cytochrome-C-reductase both in the liver and in the lungs, the probability of blocking the synthesis of phospholipids at the level of phosphatide acid and citidinephosphatecholine were noted. The results obtained should be taken into consideration during drug therapy.


Asunto(s)
Cimetidina/farmacología , Inhibidores Enzimáticos , Animales , Enfermedad Crónica , Cimetidina/uso terapéutico , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Hígado/efectos de los fármacos , Hígado/enzimología , Pulmón/efectos de los fármacos , Pulmón/enzimología , Masculino , Oxigenasas de Función Mixta/antagonistas & inhibidores , Fosfolípidos/metabolismo , Neumonía/tratamiento farmacológico , Neumonía/enzimología , Conejos , Especificidad por Sustrato/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA